Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Recruiting · NCT05174169 · Registry updated 2026-09-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colonic neoplasm, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm | Recruiting | Phase 2 / Phase 3 | 2026-09-02 | NCT05174169 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Natera, Inc. | 45 |
| National Cancer Institute (NCI) | 3015 |
| NRG Oncology | 93 |
1,077 results · Page 1 of 44
Research sites
Swipe the table sideways for more columns.